| |
| |
|
| Insider
Information: |
Hesslein Robert W. |
| Relationship: |
Senior VP & General Co... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
102,200 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$799,204 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
102,200 |
|
|
| Total
Value |
$799,204 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -42.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foundation Medicine, Inc. |
FMI |
SVP and General Counsel |
2018-07-31 |
0 |
|
0 |
Premium* |
|
|
Voyager Therapeutics, Inc. |
VYGR |
Senior VP & General Co... |
2023-03-20 |
102,200 |
2019-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2023-03-20 |
4 |
AS |
$7.76 |
$34,222 |
D/D |
(4,410) |
102,200 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2023-02-17 |
4 |
AS |
$7.45 |
$24,563 |
D/D |
(3,297) |
106,610 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2023-02-13 |
4 |
AS |
$7.67 |
$21,998 |
D/D |
(2,868) |
109,907 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2023-01-17 |
4 |
AS |
$9.57 |
$21,549 |
D/D |
(2,188) |
112,775 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2022-04-04 |
4 |
AS |
$8.25 |
$22,985 |
D/D |
(2,786) |
114,963 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2022-03-21 |
4 |
AS |
$8.29 |
$41,100 |
D/D |
(4,955) |
117,749 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2022-02-17 |
4 |
AS |
$3.55 |
$14,555 |
D/D |
(4,100) |
122,704 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2022-02-11 |
4 |
AS |
$3.36 |
$10,927 |
D/D |
(3,252) |
126,804 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2022-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
130,056 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2021-04-05 |
4 |
S |
$4.95 |
$16,295 |
D/D |
(3,292) |
110,056 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2021-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
113,348 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
83,348 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2021-02-11 |
4 |
AS |
$7.55 |
$24,054 |
D/D |
(3,186) |
49,348 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2020-04-03 |
4 |
AS |
$8.51 |
$26,304 |
D/D |
(3,091) |
52,534 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
55,625 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Senior VP & General Counsel |
• – – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,125 |
28,125 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2018-07-31 |
4 |
D |
$137.00 |
$3,933,133 |
D/D |
(28,709) |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2018-07-31 |
4 |
D |
$137.00 |
$10,479,678 |
D/D |
(76,494) |
28,709 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2018-07-02 |
4 |
S |
$136.66 |
$344,383 |
D/D |
(2,520) |
105,203 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2018-04-02 |
4 |
S |
$74.88 |
$118,685 |
D/D |
(1,585) |
107,723 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2018-04-02 |
4 |
OE |
$7.12 |
$16,689 |
D/D |
2,344 |
109,308 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2018-04-01 |
4 |
A |
$78.75 |
$678,904 |
D/D |
8,621 |
106,964 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2018-01-16 |
4 |
AS |
$64.30 |
$1,158,750 |
D/D |
(18,021) |
98,343 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2018-01-02 |
4 |
S |
$64.00 |
$119,296 |
D/D |
(1,864) |
116,364 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
SVP and General Counsel |
• – – |
2017-10-02 |
4 |
S |
$38.80 |
$84,002 |
D/D |
(2,165) |
118,228 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
